Filing Details
- Accession Number:
- 0001628280-21-017662
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-26 16:15:48
- Reporting Period:
- 2021-08-25
- Accepted Time:
- 2021-08-26 16:15:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1600620 | Aurinia Pharmaceuticals Inc. | AUPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1837720 | Neil Solomons | #1203-4464 Markham Street Victoria A1 V8Z7X8 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-08-25 | 5,000 | $15.85 | 137,299 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2021.
Billionaire Hedge Funds
